Facebook Can be Vital for Chronic Disease Management

Facebook engages more than 2 billion people, and adults over the age of 65 are increasingly more active on the site, especially when it comes to health information.

The Journal of Medical Internet Research has published an article in its January 2018 issue that looks at use of Facebook for management of chronic diseases. The authors discussed potential benefits, issues, and recommendations on Facebook group-based patient education for type 2 diabetes mellitus (T2DM) and coronary heart disease (CHD).

Facebook groups can be a solution to the face-to-face burden of chronic disease rehabilitation group-based programs. On Facebook, individuals can read and post material at any time and from any location, as part of their daily routines. This can foster self-management, and support appropriate behavior if posts deliver detailed information, patient discussions, peer support, and descriptions of worthwhile behaviors, such as exercise.

For more information, visit PharmacyTimes.com.

Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 


Most Popular

Related Articles

The FDA has announced its approval of avatrombopag (Doptelet, AkaRx) tablets to treat low blood platelet count in adults with chronic liver disease (CLD) who are scheduled to undergo a medical or dental procedure.
Antibiotic-resistant Acinetobacter baumannii infections put children with compromised immune systems in health care settings at greater risk of infections of the lung, urinary tract, and other sites.
Population-based screening was found to be associated with a reduction in admissions, physician visits, and prescribed medication for individuals diagnosed with type 2 diabetes.
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.